版权说明 操作指南
首页 > 成果 > 详情

Carbapenem-resistant Gram-negative bacteria exhibiting clinically undetected cefiderocol heteroresistance leads to treatment failure in a murine model of infection

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Liu, Hongwei;Zhou, Peng;Ma, Peng;Liu, Yaqin;Zhang, Yingfeng;...
通讯作者:
Yin, Weiguo;Li, Linhai;Lu, Y
作者机构:
[Li, Linhai; Liu, Hongwei; Yin, Weiguo; Ma, Peng; Lu, Yang; Liu, Yaqin; Zhou, Peng; Lu, Y; Xu, Lingqing; Yin, WG] Guangzhou Med Univ, Affiliated Qingyuan Hosp, Qingyuan Peoples Hosp, Qingyuan, Peoples R China.
[Zhang, Yingfeng] Univ South China, Sch Publ Hlth, Hengyang Med Sch, Dept Publ Hlth Lab Sci, Hengyang, Peoples R China.
[Li, Qiwei] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Lab Med, Guangzhou, Peoples R China.
[Yuan, Wenchang] Guangzhou Med Univ, KingMed Sch Lab Med, Guangzhou, Peoples R China.
通讯机构:
[Li, LH; Lu, Y ; Yin, WG] G
Guangzhou Med Univ, Affiliated Qingyuan Hosp, Qingyuan Peoples Hosp, Qingyuan, Peoples R China.
语种:
英文
关键词:
carbapenem resistance;cefiderocol;failure treatment;gene mutation;heteroresistance
期刊:
Frontiers in Microbiology
ISSN:
1664-302X
年:
2025
卷:
16
页码:
1496514
基金类别:
Medical Scientific Research Foundation of Guangdong Province, China [B2022198]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20231408, 20232036]; Natural Science Foundation of Guangdong Province [2021A1515011360]
机构署名:
本校为其他机构
院系归属:
公共卫生学院
摘要:
INTRODUCTION: Carbapenem-resistant (CR) Gram-negative pathogens are classified by the WHO as critical threats due to limited therapeutic options. Cefiderocol (CFD), a novel siderophore cephalosporin, shows promise but remains unapproved in China. This study investigated the prevalence, clinical impact, and genetic mechanisms of cefiderocol heteroresistance (CFD-HR) in CR and ESBL-producing clinical isolates from China, where CFD remains unapproved. METHODS: A total of 407 CR and ESBL-producing isolates were analyzed. CFD-HR was identified by po...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com